CHI3L1 and CHI3L3 levels were highest in the CD45+ fraction of 4T1 primary tumors (Fig. 3F), identifying immune rather than tumor cells as major producers of both CLPs in the TME. This evidence concerns the gene CHI3L1 and neoplasm.